Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 3/20 | 0.69 |
| ▸ | CDK2 | P24941 | 3/20 | 0.69 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.69 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.69 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.55 |
| ▸ | NPC1 | O15118 | 9/20 | 0.55 |
| ▸ | RAB9A | P51151 | 9/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.55 |
| ▸ | HPGD | P15428 | 7/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | ATR | Q13535 | 1/20 | 0.51 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4098969 | 0.83 | CDK1 (0.69) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL5117922 | 0.82 | CDK1 (1.00) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL992234 | 0.82 | PDE5A (0.52) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| Hydrochloric Acid SCHEMBL5116173 | 0.81 | CDK1 (0.97) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL31217273 | 0.80 | AMY1A (0.59) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL18155110 | 0.80 | AMY1A (0.59) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL31658934 | 0.79 | ALDH1A1 (0.67) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL2680638 | 0.79 | CDK1 (0.79) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL2681945 | 0.79 | CDK1 (0.83) | CDK1CDK2MKNK1MKNK2PDPK1 | |
| SCHEMBL2682567 | 0.79 | CDK1 (0.79) | CDK1CDK2MKNK1MKNK2PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8648201-B2 | Aminopyridine derivatives for treating tumors and inflammatory diseases | MERCK PATENT GMBH (DE) | 2014-02-11 | — | — | US | disclosed |
| US-20120115861-A1 | AMINOPYRIDINE DERIVATIVES FOR TREATING TUMORS AND INFLAMMATORY DISEASES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120115861-A1 | AMINOPYRIDINE DERIVATIVES FOR TREATING TUMORS AND INFLAMMATORY DISEASES | PDK1, PDK2, PDK4 | CDK1 15/4885CDK2 10/4885MKNK1 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.